Suppr超能文献

根据组织学模式和增殖活性划分的骨髓瘤患者风险组。

Risk groups of myeloma patients by histologic pattern and proliferative activity.

作者信息

Pich A, Chiusa L, Marmont F, Navone R

机构信息

Department of Biomedical Sciences and Human Oncology, University of Turin, Italy.

出版信息

Am J Surg Pathol. 1997 Mar;21(3):339-47. doi: 10.1097/00000478-199703000-00011.

Abstract

We investigated the histologic pattern and the cell proliferative activity of myeloma cells by the analysis of the nucleolar organizer regions (AgNORs) in bone marrow biopsy specimens from 150 multiple myelomas at diagnosis. The objective was an attempt to define risk groups of myeloma patients. On univariate analysis, the percentage of bone marrow plasma cells (BMPC%), the pattern of infiltration, the degree of plasma cell (PC) atypia, the marrow fibrosis, and the number of AgNOR/PC were correlated with survival time. On multivariate analysis, only AgNOR counts and pattern of infiltration retained independent prognostic significance. At 4-year followup, all patients with BMPC% < or = 20, interstitial pattern of invasion, and well-differentiated (G1) PC plus AgNOR/cell < or = 3.32 were alive, while no patient with BMPC% >50, diffuse pattern of infiltration, and poorly differentiated (G3) PC plus AgNOR/cell >5.15 survived (p < 0.0001). In conclusion, the histologic pattern and proliferative activity of myeloma cells, evaluated by AgNOR counts, are reliable predictors of survival in myeloma. Both parameters can be easily assessed in the same biopsy specimen, are reproducible, and permit identification of a group of patients with favourable outcome at 4-year followup. Thus, bone marrow biopsy should always be included in the diagnostic procedures for myeloma patients.

摘要

我们通过分析150例初诊多发性骨髓瘤患者骨髓活检标本中的核仁组成区(AgNORs),研究了骨髓瘤细胞的组织学模式和细胞增殖活性。目的是试图界定骨髓瘤患者的风险组。单因素分析显示,骨髓浆细胞百分比(BMPC%)、浸润模式、浆细胞(PC)异型程度、骨髓纤维化以及AgNOR/PC数量与生存时间相关。多因素分析显示,只有AgNOR计数和浸润模式具有独立的预后意义。在4年随访时,所有BMPC%≤20、间质浸润模式、高分化(G1)PC且AgNOR/细胞≤3.32的患者均存活,而BMPC%>50、弥漫浸润模式、低分化(G3)PC且AgNOR/细胞>5.15的患者无一存活(p<0.0001)。总之,通过AgNOR计数评估的骨髓瘤细胞组织学模式和增殖活性是骨髓瘤患者生存的可靠预测指标。这两个参数均可在同一活检标本中轻松评估,具有可重复性,并且能够在4年随访时识别出一组预后良好的患者。因此,骨髓瘤患者的诊断程序应始终包括骨髓活检。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验